探討空間分割放療在腫瘤治療中的功效和毒性。
適應症：Radiotherapy-Induced Immune Priming
收案條件
納入條件
- Patients with a bulky solid tumor with a maximum diameter \>4 cm or a refractory solid tumor.
排除條件
- Tumors involving hollow viscera that are considered to have a clinically significant risk of bleeding or perforation.
- Patients with impaired consciousness or who are unable to care for themselves.
收案條件維持 ClinicalTrials.gov 原始英文登錄資料，實際收案資格以研究團隊的正式評估與受試者同意書為準。資料來源：ClinicalTrials.gov，每兩週自動更新，最後同步：2026年10月8日。